We probed the substrate specificity of a recombinant noncovalent complex of the full-length hepatitis C virus (HCV) NS3 serine protease and NS4A cofactor, using a series of small synthetic peptides derived from the three trans-cleavage sites of the HCV nonstructural protein sequence. We observed a distinct cleavage site preference exhibited by the enzyme complex. The values of the turnover number (k cat ) for the most efficient NS4A/4B, 4B/5A, and 5A/5B peptide substrates were 1.6, 11, and 8 min Hepatitis C virus (HCV) is the major etiological agent of human posttransfusion and community-acquired non-A, non-B hepatitis (1, 10, 29) , infecting an estimated 1% of the global population (35). Infection by HCV may lead to chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (7, 36) . HCV is a small enveloped virus containing a positive-stranded linear RNA genome of approximately 9.5 kb in size (25). The HCV genome encodes a single large polyprotein of approximately 3,000 amino acids (11, 44). The polyprotein contains both structural and nonstructural (NS) proteins (C-E1-E2-p7-NS2-NS3-NS4A-NS4B-NS5A-NS5B), which are proteolytically processed by either host signal peptidases or two viral proteases, NS2/NS3 and NS3 (19, 23, 30) . Cleavage of the viral polyprotein between NS2 and NS3 is accomplished in cis by a zincdependent protease activity (18, 24) . The protease located in the N-terminal domain of NS3 in turn cleaves its C-terminal nonstructural polyprotein sequence at the junctions of NS3/ 4A, 4A/4B, 4B/5A, and 5A/5B (3, 17, 48) . The NS4B/5A cleavage by the NS3 protease requires NS4A as an obligatory cofactor which forms a stable complex with NS3 (2, 15, 31) . Interaction between NS3 and NS4A is known to involve the central hydrophobic domain of NS4A and the N-terminal 22 residues of NS3 (5, 14, 27, 39, 46) . The protease catalytic domain in NS3 is located within its first N-terminal 180 amino acid residues. A catalytic triad characteristic of serine proteases (His-Asp-Ser) was readily identified based on sequence alignment (17). Inhibition of the HCV NS3 protease by some chymotrypsin/trypsin-specific inhibitors (N-tosyl-L-phenylalanine chloromethyl ketone, N-tosyl-L-lysine chloromethyl ketone, chymostatin, and 4-(-aminoethyl)-benzenesulfonyl-fluoride) suggested that the HCV NS3 protease may be a chymotrypsin/trypsin-like serine protease (21, 32, 34). Furthermore, substrate specificity of the HCV NS3 protease was redesigned to conform to that of Streptomyces griseus protease B on the basis of a trypsin homology model (16). Recent structural determinations of the catalytic domain of the HCV NS3 protease in the absence or presence of the NS4A cofactor peptide confirmed that the protease has a trypsin/chymotrypsin-like structural fold (27, 33) . The HCV NS3 protease may play as essential a role in virus growth as its counterparts from other members of the family Flaviviridae (8) and therefore may be a major target for anti-HCV therapy.
Hepatitis C virus (HCV) is the major etiological agent of human posttransfusion and community-acquired non-A, non-B hepatitis (1, 10, 29) , infecting an estimated 1% of the global population (35) . Infection by HCV may lead to chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (7, 36) . HCV is a small enveloped virus containing a positive-stranded linear RNA genome of approximately 9.5 kb in size (25) . The HCV genome encodes a single large polyprotein of approximately 3,000 amino acids (11, 44) . The polyprotein contains both structural and nonstructural (NS) proteins (C-E1-E2-p7-NS2-NS3-NS4A-NS4B-NS5A-NS5B), which are proteolytically processed by either host signal peptidases or two viral proteases, NS2/NS3 and NS3 (19, 23, 30) . Cleavage of the viral polyprotein between NS2 and NS3 is accomplished in cis by a zincdependent protease activity (18, 24) . The protease located in the N-terminal domain of NS3 in turn cleaves its C-terminal nonstructural polyprotein sequence at the junctions of NS3/ 4A, 4A/4B, 4B/5A, and 5A/5B (3, 17, 48) . The NS4B/5A cleavage by the NS3 protease requires NS4A as an obligatory cofactor which forms a stable complex with NS3 (2, 15, 31) . Interaction between NS3 and NS4A is known to involve the central hydrophobic domain of NS4A and the N-terminal 22 residues of NS3 (5, 14, 27, 39, 46) . The protease catalytic domain in NS3 is located within its first N-terminal 180 amino acid residues. A catalytic triad characteristic of serine proteases (His-Asp-Ser) was readily identified based on sequence alignment (17) . Inhibition of the HCV NS3 protease by some chymotrypsin/trypsin-specific inhibitors (N-tosyl-L-phenylalanine chloromethyl ketone, N-tosyl-L-lysine chloromethyl ketone, chymostatin, and 4-(-aminoethyl)-benzenesulfonyl-fluoride) suggested that the HCV NS3 protease may be a chymotrypsin/trypsin-like serine protease (21, 32, 34) . Furthermore, substrate specificity of the HCV NS3 protease was redesigned to conform to that of Streptomyces griseus protease B on the basis of a trypsin homology model (16) . Recent structural determinations of the catalytic domain of the HCV NS3 protease in the absence or presence of the NS4A cofactor peptide confirmed that the protease has a trypsin/chymotrypsin-like structural fold (27, 33) . The HCV NS3 protease may play as essential a role in virus growth as its counterparts from other members of the family Flaviviridae (8) and therefore may be a major target for anti-HCV therapy.
Elucidating the substrate specificity of the HCV NS3 protease is important for the development of high throughput assays for random screening of HCV protease inhibitors and for the rational design of HCV protease-specific inhibitors. Sequence comparison among isolated HCV strains has revealed structurally conserved residues flanking the cleavage sites between NS3, NS4A, NS4B, NS5A, and NS5B (17), namely (i) an acidic residue (Asp or Glu) at the P6 position, (ii) a Cys (for trans-cleavage) or Thr (for cis-cleavage) residue at the P1 position, and (iii) a Ser or Ala residue at the P1Ј position. Mutational analysis with truncated polyprotein substrates showed that the NS3/4A cis-cleavage site can accommodate more substitutions near the scissile bond than transcleavage sites and that the P6 acidic residue was not critical (4, 28) . Furthermore, substitutions at the P1 position of transcleavage sites were not as well tolerated as substitutions at the P1Ј position (4). The crystal structure of the HCV NS3 protease domain shed additional light on the substrate-binding pocket (27, 33) . The S1 pocket of the NS3 protease was shallow and nonpolar, formed primarily by the side chains of three invariant hydrophobic residues, Phe-154 at the bottom and Ala-157 and Leu-135 on either side. The remaining substratebinding channel is rather solvent exposed and unlikely to provide any significant interactions with the side chains of the P2 to P6 residues. Substrate specificity studies with synthetic peptide substrates have not been thoroughly investigated for the HCV proteases, other than several studies on the use of peptide substrates for assay development (6, 41, 42) , some kinetic studies on the NS5A/5B-and 4B/5A-derived peptide substrates (26, 40) , and a recent study on substrate specificity at the NS4A/4B site (49) .
We report here our results from probing substrate specificity with synthetic peptides derived from all three trans-cleavage sites (NS4A/4B, 4B/5A, and 5A/5B), with emphasis on NS5A/ 5B as a model substrate for studying the substrate specificity of the HCV NS3 protease. Unlike other studies using the catalytic domain (ϳ180 residues) of the NS3 protease and some truncated forms (ϳ13-mer) of the NS4A cofactor peptide, the protease construct employed in our substrate specificity studies was the full-length HCV NS3(1-631)/4A(1-54) complex expressed in a baculovirus system (37) . The protease complex, containing an N-terminal His tag, was spontaneously generated by an intramolecular (cis) cleavage and purified to greater than 95% purity by nickel-nitrilotriacetic acid affinity chromatography. The His tag was then cleaved by thrombin to yield the NS3/4A protease used in the present study.
Steady state kinetic analysis of HCV synthetic peptide substrates. Peptides were synthesized on an automated ABI model 431A synthesizer (Applied Biosystems, Foster City, Calif.) with 9-fluorenylmethoxycarbonyl (Fmoc) chemistry and online conductivity monitoring during Fmoc deprotection steps. Alternatively, parallel manual synthesis was employed, especially for generating alanine-scanning peptides. The molecular mass of each purified peptide was confirmed by time-of-flight plasma desorption or electrospray ionization mass spectroscopy (Applied Biosystems).
Michaelis-Menten steady-state kinetics were established by using substrate concentrations two to three orders of magnitude higher than the HCV NS3/4A protease concentration and allowing less than 10% cleavage of the substrate by the protease (47) . Reactions were performed at 23°C in 25 mM Tris-25 mM sodium phosphate (pH 7.5) containing 10% glycerol, 0.1% Nonidet P-40, 150 mM NaCl, and 10 mM dithiothreitol. A high-performance liquid chromatography-based peptide cleavage assay was developed to measure the extent of substrate cleavage. The formation of the PЈ product was used to follow the kinetics of cleavage reactions. The identities of the products were confirmed on the basis of coelution of synthetic standards, amino acid sequencing, and mass analysis. In all cases, the cleavage reactions occurred at the same residue locations as in the polyprotein processing, and control experiments were performed to confirm that the cleavage reaction was specific for the HCV NS3/4A protease. Michaelis-Menten constants (K m ) and maximal velocities (V max ) were obtained from nonlinear least-squares fit of initial velocity data to the Michaelis-Menten equation. The turnover numbers (k cat ) were calculated from V max /E T , where the total enzyme amount (E T ) was estimated from amino acid analysis. All of the enzyme was assumed to be active. Therefore, the apparent k cat and k cat /K m values reported in all of the tables are the lowest estimates for the protease. For peptides with K m values less than 1 mM, we have accurately determined the k cat and K m values by employing a substrate concentration range from less than half to between 4 and 10 times their K m values. For peptides with poor K m values (Ͼ1 mM), only apparent k cat /K m ratios were determined accurately and reported, whereas estimates for individual k cat and K m values were not reported. The estimated errors for kinetic parameters were in the range of 10 to 30%. Shown in Fig. 1A is the variation in initial velocity of cleavage of an NS5A/5B P8P8ЈK substrate as a function of HCV NS3/4A protease concentration. The initial velocity was linear throughout the protease concentration range tested (13 to 420 nM). Michaelis-Menten steady-state kinetic data obtained with the NS5A/5B P8P8ЈK substrate at 42 nM NS3/4A protease is shown in Fig. 1B . The k cat and K m values for this substrate were determined to be 9.8 min Ϫ1 and 20 M, respectively (see summary in Table 1 ).
Site and length dependence of peptide cleavage. Since the HCV NS3/4A protease cleaves in trans at three different sites within the nonstructural polyprotein, our first interest was in comparing the relative cleavage efficiency of peptide substrates derived from each site. Summarized in Table 1 ) and provide the basis for two important observations. First, the catalytic efficiency of the NS3/4A protease is cleavage site dependent, increasing in the overall rank order of NS4A/4B to NS4B/5A to NS5A/5B for peptides of comparable length, as measured by an increase in k cat and decrease in K m values. In pairwise comparison, the difference in catalytic efficiency for cleavage was reflected by either a change in k cat (NS4A/4B P10P9Ј versus NS4B/5A P10P10Ј), a change in K m (NS4B/5A P10P10Ј versus NS5A/5B P8P8Ј), or a combination of both effects (NS4A/4B P10P9Ј versus NS5A/5B P8P8ЈK). Second, the catalytic efficiency of the NS3/4A protease is peptide length dependent, such that terminal truncations of the longer peptides (15-to 20-mer) yielded significantly weaker substrates (10-or 15-mer). The sharp decrease in k cat /K m values observed with shorter (10-to 15-mer) synthetic peptides (P6P4Ј of NS4A/4B and 5A/5B and P8P7Ј of NS4B/5A [ Table 1 ]) is primarily a result of the increase in K m values. This length-dependent phenomenon suggests that amino acid residues that are distant from the scissile bond may contribute significantly to substrate binding by direct physical contact and/or indirect conformational influence.
Synthetic peptide substrates were cleaved with relatively low catalytic efficiency by various constructs of the NS3 serine protease (6, (40) (41) (42) 49) . Higher catalytic efficiency was achieved by substituting the scissile peptide bond with an ester linkage as in depsipeptide analogs (6, 45) . In our current report, we show that NS3/4A cleaves the NS4A/4B and 4B/5A peptides (10-to 15-mer) with catalytic efficiency values (38 to 92 M Ϫ1 s Ϫ1 [ Table 1 ]) which are comparable to those reported in previous studies, despite the use of different protease constructs and assay conditions by the different groups. Exceptionally, a construct containing an NS3 protease fused to a maltose-binding protein was not able to cleave the 14-mer NS4A/4B and 4B/5A peptide substrates (40) .
In contrast to the NS4A/4B and 4B/5A peptides, the NS5A/ 5B P8P8ЈK peptide substrate was most efficiently cleaved by HCV NS3/4A (Table 1) . A similar finding was reported by others (42) using an NS3 protease catalytic domain and shorter (P6P4Ј) substrates. It is known that cleavage at the NS5A/5B site can occur in the absence of NS4A, whereas cleavage at NS4B/5A by the NS3 protease requires NS4A as a cofactor (15, 39, 46) . These findings and our data implicate NS5A/5B as the kinetically most-favored site of trans-cleavage in the HCV polyprotein. The kinetics of processing for HCV nonstructural proteins transiently expressed in HeLa cells (2) suggested a rapid cis-cleavage at NS3/4A followed by trans-cleavages in the order of NS5A/5B and 4B/5A first and NS4A/4B last, although a similar processing kinetic study carried out in HepG2-A16 cells (31) detected multiple pathways. It is unclear whether this type of kinetic multiplicity, or a preferred temporal sequence of processing HCV nonstructural proteins, occurs in cells infected with HCV.
The kinetic parameters of peptide cleavage by the HCV NS3/4A protease reported in Table 1 (12, 13, 22) and HCMV proteases (38) , respectively. Nevertheless, it is important to recognize that viral proteases might cleave synthetic peptides and intact protein substrates with distinct catalytic efficiencies.
Alanine scanning of the NS5A/5B substrate peptide. Since the NS5A/5B-derived peptides were the most efficient substrates for cleavage, we focused on this site for more in-depth substrate specificity studies. We first examined the relative importance of side chains in the cleavage of the NS5A/5B substrate peptide by alanine-scanning studies. To facilitate parallel manual synthesis, we chose to use the 11-mer NS5A/5B P6P4ЈK as a template for alanine (Ala) substitutions ( Table 2 ). The results show that residues P2 Cys, P1Ј Ser, and P3Ј Ser could be replaced by Ala with little effect on the catalytic efficiency of NS3/4A, whereas replacement of P1 Cys and P3 Val with Ala resulted in complete inactivation of the substrate. Substitutions at P6 Glu, P5 Asp, P4 Val, P2Ј Met, and P4Ј Tyr produced substrates which were cleaved by the enzyme at ca. 5-to 20-fold lower catalytic efficiency. A previously reported alanine-scanning study with an HCV NS4A/4B P6P4Ј peptide substrate also revealed that the P1 and P3 residues of NS4A/4B were most important (49) .
Similar observations for the requirement of critical residues distant from the scissile bond have been reported for other proteases such as subtilisins (20) , thrombin (43) , and those of HSV-1 (13) and HCMV (38) . The structural basis for this type of stringent substrate specificity is the presence of a second specificity pocket (S4 site) in subtilisins (20) , an anion-binding exosite in thrombin (43) , or an elongated shallow cleft in the HCMV protease (9) . Recent structural elucidation of the HCV NS3 protease catalytic domain also revealed a similarly extended, shallow substrate-binding groove (27, 33) . A combination of two or more residues critical for substrate binding and catalysis could introduce the required substrate specificity for the protease. Unlike many enzymes, which perform numerous rounds of turnover for substrate in great molar excess, the viral b Peptides derived from HCV trans-cleavage sites are designated according to the nomenclature for peptide substrates. All sequences are from the HCV-1a (H) strain. All peptides are amidated except the NS5A/5B peptides ending with lysine (K). Ac, N-acetyl. protease generally needs to carry out one or a few highly specific cleavages for its cotranslated protein substrate during intracellular viral maturation. This may help explain why the turnover numbers and catalytic efficiencies observed for the HCV protease and other viral proteases are low compared to classical proteases such as trypsin and chymotrypsin.
P1 Cys substitutions in the NS5A/5B substrate peptide. We further probed the stereochemical requirement for the critical P1 Cys residue, a residue strictly conserved in all trans-cleavage sites. Analysis of its structure-activity relationships (SAR) may guide the rational design of HCV NS3/4A-specific inhibitors. We chose a set of residues that alter the sulfhydryl and/or steric characteristics (bulkiness and chirality) of Cys. To minimize synthetic and Cys oxidation problems, we performed the studies on the modified NS5A/5B P8P8ЈK peptide in which the second and nonessential Cys at the P2 position was replaced by Ala, giving rise to a substrate as competent as the unsubstituted NS5A/5B P8P8ЈK ( Table 3) . As shown in Table 3 , substitutions at the P1 position by a series of residues including homocysteine (Hcy), S-methylcysteine (Mcy), Ala, S-ethylcysteine (Ecy), Thr, Met, D-Cys, Ser, and penicillamine (Pen) resulted in a progressive decrease in catalytic efficiency reflected by a decrease in k cat values and a concomitant increase in K m values.
The fact that D-Cys was not well tolerated at P1 indicates a stereospecific S1 binding pocket for L-Cys. When an L-Cys analog, ␤,␤-dimethylcysteine, also known as penicillamine (Pen), was introduced into the P1 position, the P1 Pen peptide was poorly cleaved. This may be due to the increased steric bulkiness introduced by the two additional methyl groups at the ␤-carbon, revealing a rather narrow S1 pocket for the P1 Cys residue. On the other hand, the P1 Hcy peptide containing a homocysteine (Hcy) substitution, which has one more methylene group than Cys, was the best P1 mutant peptide, quite efficiently cleaving with a twofold increase in K m and a ninefold decrease in k cat . When a methyl group was added to the sulfur atom in Cys or Hcy, the resultant P1 Mcy and P1 Met was 30-and 10-fold weaker, respectively. Addition of an ethyl group to the Cys sulfhydryl yielded a P1 Ecy substitution that was 180-fold weaker than P1 Cys. Together the data suggest that the stereospecific S1 pocket is both narrow and shallow, capable of accommodating no more than two extra methylene groups to effect any detectable cleavage. All of the non-native side chains of the P1 mutant residues in the S1 pocket probably caused the scissile bond to be less than optimally presented to the catalytic triad, such that the rate of acylation and/or deacylation as reflected by k cat values were all reduced significantly, at least 9-(P1 Hcy) to 89-fold (P1 Met and Ser).
When the sulfhydryl was replaced by a smaller and less nucleophilic hydroxyl, as in the P1 Ser substitution, the P1 Ser peptide was a very inefficient substrate (1,700-fold reduction in catalytic efficiency [ Table 3 ]). The inefficiency of P1 Ser was probably due to poor interaction with the aromatic ring of Phe-154 in the S1 pocket of NS3 protease. When the sulfur atom was eliminated altogether, as in the P1 Ala substitution, the catalytic efficiency decreased 140-fold (compare P1 Ala with the P1 Cys peptide [ Table 3 ]). The available data suggest that the sulfhydryl group may play a critical role in substrate binding, a role that cannot be filled by a hydroxyl group in Ser. However, the P1 Thr substitution, which has an added ␤-methyl group compared to Ser, was ninefold more efficient than the P1 Ser substitution. The P1 Thr-substituted peptide was cleaved with a catalytic efficiency of 28 M Ϫ1 s
Ϫ1
, compared to 3 M Ϫ1 s Ϫ1 for the P1 Ser-substituted peptide (Table 3) as a result of a 10-fold higher turnover number. These nonsulfhydryl P1 substitutions (Thr, Ala, and Ser) collectively revealed that sulfhydryl is critical and may be partially compensated for by a bulkier ␤-methyl group but not by a smaller group such as a hydroxyl.
Taken together, the P1 substitution SAR data revealed a strict stereochemical requirement for the P1 residue by the S1 binding pocket; that is, the native L-Cys is the most efficient P1 residue, and alteration of the sulfhydryl function and/or the steric characteristics (bulkiness or chirality) resulted in a 20-to 12,500-fold loss of cleavage efficiency.
In summary, we have probed the substrate specificity for the full-length HCV NS3/4A serine protease complex by using a series of synthetic peptides as model substrates. We noted a site and length dependence of the trans peptide cleavage by the protease. Using the alanine-scanning and P1 substitution SAR studies on the NS5A/5B substrate peptide, we discovered two critical residues in the NS5A/5B substrate, P1 Cys and P3 Val. P1 substitution SAR studies revealed that the native P1 Cys is the best residue for satisfying the stereochemical requirement by the S1 pocket of the HCV NS3/4A protease in trans-cleavage reactions. It is noteworthy that the P1 position at the NS3/4A cis-cleavage site is much less stringent, such that Cys, Met, and Ala can all replace the native Thr without loss of cleavage efficiency in transient expression HeLa cells (4) . Our data suggest that the S1 pocket in NS3/4A may be substantially different in cis-cleavage (when NS3 and NS4A are covalently linked) and trans-cleavage (when NS3 and NS4 are noncovalently bound). The substrate specificity study described in this paper, together with crystal structure information, provide the preliminary basis for the rational design of HCV NS3 protease inhibitors as effective anti-HCV therapy.
